#MondayTips
Every Monday, WSA Social Media Leader Rodrigo Guerrero publishes a #MondayTip on the WSA WorldStrokeEd Twitter account, covering a specific stroke related topic. You can find a compilation of our #MondayTips here!
Every Monday, WSA Social Media Leader Rodrigo Guerrero publishes a #MondayTip on the WSA WorldStrokeEd Twitter account, covering a specific stroke related topic. You can find a compilation of our #MondayTips here!
May #PaperofTheMonth: πππππππ-ππππππ: π
ππππ¨π« πππ ππ§π‘π’ππ’ππ’π¨π§ ππππ©π¬ π’π§ππ¨ ππππ¨π§πππ«π² πππ«π¨π€π ππ«ππ―ππ§ππ’π¨π§
π€Commentary
π½#MondayTip
π§4 expert interview episodes
Access it: https://www.world-stroke-academy.org/news/the-paper-of-the-month-may-4/
#StrokeEducation
#MondayTip
#TRIDENT
πOne pill could change post-ICH care.
π§ Low-dose triple antihypertensive therapy β recurrent stroke by 39% and improved BP control vs standard care
βοΈSimpler regimens may beat therapeutic inertia
πhttps://doi.org/10.1056/nejmoa2515043
#MondayTip
#Tenecteplase may helpβeven when the artery stays closed.
In #TRACE3 (4.5β24h window), pts without recanalization still had better outcomes (42% vs 30%). Strongest effect in NIHSS β₯10.
π Think beyond large vessel reopening
https://doi.org/10.1186/s12916-026-04877-x
#MondayTip
Can we prevent stroke without increasing bleeding?
Factor XIa inhibition #asundexian :
πΉβ¬οΈrecurrent stroke (HR 0.74)
πΈwith no β¬οΈmajor bleeding in OCEANIC-STROKE.
A potential shift in secondary prevention. π§ βοΈ
π https://www.nejm.org/doi/full/10.1056/NEJMoa2513880
#MondayTip
#GFAP
πRises early in intracerebral hemorrhage (2β6h)π©Έ, but later in ischemic stroke (peak days 2β5)
π‘Promising for early differentiation & triage
βοΈbut not ready as a standalone test
https://doi.org/10.3390/jcm14217748
#MondayTip
#Collaterals
Collateral status are relevant in stroke
π§ Good collaterals + recanalization β strong outcomes
β οΈ Poor collaterals β limited benefit, even if opened
CTA isnβt just diagnosticβitβs decision-making
https://doi.org/10.3174/ajnr.a3817
#MondayTip
Cancer-related stroke β routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
π14β29% recur at 1 year
βοΈAnticoag vs aspirin? Still equipoise
π§ Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTip
Hypoperfusion Intensity Ratio
#HIR may be the most practical collateral biomarker in AIS
β¬οΈHigh HIR (>0.4) β rapid core growth, β hemorrhage risk, worse mRS.
β¬οΈLow HIR β robust collaterals & better EVT outcomes.
https://doi.org/10.3174/ajnr.A8557
Missed what happened in February at @WorldStrokeEd? π
Catch up with our monthly newsletter!
π Upcoming & past webinars
ποΈ New podcast episodes
π Fresh infographics
π‘ Latest #MondayTips by @interneurona
π€ Read it here:
https://www.world-stroke-academy.org/news/february-newsletter-3/
#StrokeEducation #StrokeCare
#MondayTip
Not all βseizuresβ are epilepsy.
π§ #LimbShakingTIA = hypoperfusion from carotid disease
π Triggered by standing/exertion
π EEG often normal
β οΈ Treat flow, not firing
https://doi.org/10.1136/pn-2025-004976
#MondayTip
New AHA dyslipidemia guides emphasizes earlier &β intensive LDL-Cβ¬οΈ, often requiring non-statin therapy
PCSK9 options:
π§¬Inclisiran (siRNA):βPCSK9 production, dosing every 6m
πAlirocumab/Evolocumab:βcirculating PCSK9
Both βLDL~50β60%, including in stroke patients
Missed what happened in February at @WorldStrokeEd? π
Catch up with our monthly newsletter!
π Upcoming & past webinars
ποΈ New podcast episodes
π Fresh infographics
π‘ Latest #MondayTips by @interneurona
π€ Read it here:
https://www.world-stroke-academy.org/news/february-newsletter-3/
#StrokeEducation #StrokeCare
#MondayTip
#Stroke is not the same in #women and men
βοΈWomen have unique risk factors (pregnancy complications, menopause), are more likely to be misdiagnosed, rec&eive thrombolysis less often, despite similar benefit
Time for sex-responsive stroke care
https://doi.org/10.1177/17474930251393009
#MondayTip
Hypoperfusion Intensity Ratio
#HIR may be the most practical collateral biomarker in AIS
β¬οΈHigh HIR (>0.4) β rapid core growth, β hemorrhage risk, worse mRS.
β¬οΈLow HIR β robust collaterals & better EVT outcomes.
https://doi.org/10.3174/ajnr.A8557
#MondayTip
Cancer-related stroke β routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
π14β29% recur at 1 year
βοΈAnticoag vs aspirin? Still equipoise
π§ Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTip
Cancer-related stroke β routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
π14β29% recur at 1 year
βοΈAnticoag vs aspirin? Still equipoise
π§ Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
May #PaperofTheMonth: πππππππ-ππππππ: π
ππππ¨π« πππ ππ§π‘π’ππ’ππ’π¨π§ ππππ©π¬ π’π§ππ¨ ππππ¨π§πππ«π² πππ«π¨π€π ππ«ππ―ππ§ππ’π¨π§
π€Commentary
π½#MondayTip
π§4 expert interview episodes
Access it: https://www.world-stroke-academy.org/news/the-paper-of-the-month-may-4/
#StrokeEducation
πFollowing #WorldHypertensionDay, we are pleased to invite you to our upcoming webinar on ππ²π©ππ«πππ§π¬π’π¨π§ ππ§π ππ§ππ«ππππ«πππ«ππ₯ πππ¦π¨π«π«π‘ππ π
ποΈJune 24th, 2-3pm (CEST)
https://l1nq.com/n59h38h
π€@WorldStrokeOrg @WorldHyperLeag @GeorgeMedicines
π’ Still time to register for the #ESOC2026 Highlights Webinar to explore the most important advances in #stroke research & care.
Organised by @American_Stroke, ESO & @WorldStrokeOrg
πhttps://ow.ly/gZ7950YR0Sk
@American_Heart @FishingNeurons @bijoymenon @sheilambrasil @SposatoL
π’ Join the #ESOC2026 Highlights Webinar on 21 May, to explore the most important advances in #stroke research &clinical care.
Organised by @American_Stroke, ESO & @WorldStrokeOrg
πhttps://ow.ly/gZ7950YR0Sk
@American_Heart @FishingNeurons @bijoymenon @sheilambrasil @SposatoL
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |